OviTex – Nucleus Medical Media
005_tela_ovitex.jpg
Bravo 2-Year Study | TELABIO-Science.Value.Innovation
JCM | Free Full-Text | A Prospective, Single Arm, Multi-Center Study Evaluating the Clinical Outcomes of Ventral Hernias Treated with OviTex® 1S Permanent Reinforced Tissue Matrix: The BRAVO Study 12-Month Analysis
TELA Bio Investor Presentation Aug 2023
Premier Contract & Resources | TELABIO-Science.Value.Innovation
Polymers | Free Full-Text | A Polymer-Biologic Hybrid Hernia Construct: Review of Data and Early Experiences
Premier Contract & Resources | TELABIO-Science.Value.Innovation
MedicalResearch.com | Two Studies Evaluate OviTex Reinforced BioScaffolds for Hernia and Soft Tissue Repair
In-vivo evaluation of a reinforced ovine biologic: a comparative study to available hernia mesh repair materials | Hernia
Semi-quantitative abscess analysis demonstrates significantly lower... | Download Scientific Diagram
Contamination of hybrid hernia meshes compared to bioresorbable Phasix™ Mesh in a rabbit subcutaneous implant inoculation model. - Abstract - Europe PMC
TELA Bio Stock Plugging Away (NASDAQ:TELA) | Seeking Alpha
Inguinal Hernia: To Mesh or Not to Mesh? - Minnesota Hernia Center
OviTex® Reinforced Tissue Matrix · GD Medical
Bravo 2-Year Study | TELABIO-Science.Value.Innovation
TELA Bio | OviTex Reinforced Tissue Matrix
Go Natural
TELA Bio: Tailwinds In Hernia Repair Market, Promising Clinical Data (TELA) | Seeking Alpha
Comparison of mechanical properties and host tissue response to OviTex™ and Strattice™ surgical meshes | Hernia
TelaBio, F10246-1822P, Tela Bio OviTex 1S Reinforced BioSc... - eSutures
How TELA Bio Is Working to Improve Surgical Mesh Options
